Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Sarcoma, Kaposi 2HIV Infections 2Acquired Immunodeficiency Syndrome 2

Interventions

Zidovudine 6tecogalan 4Vincristine 3Specimen Handling 3Nivolumab 3Magnetic Resonance Spectroscopy 3Interferon alpha-2 3Doxorubicin 3Bleomycin 3sargramostim 2pomalidomide 2pembrolizumab 2liposomal doxorubicin 2interferon alfa-n1 2Etoposide 2Docetaxel 2Biopsy 2valspodar 1technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1entinostat 1efineptakin alfa 1cabozantinib 1Zalcitabine 1Tumor Necrosis Factor-alpha 1Thalidomide 1Sorafenib 1Sirolimus 1Semaxinib 1SUB1 protein, human 1O-(Chloroacetylcarbamoyl)fumagillol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Sarcoma, Kaposi × interferon alfa-n1 × Clear all
NCT00001113 2021-11-04

A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed
48 enrolled
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

NCT00000725 2021-11-03

A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed
56 enrolled
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡